E Melillo, KL Woolley, PJ Manning, RM Watson and PM O'Byrne
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Previous studies have suggested that the endogenous release of inhibitory prostanoids limits the bronchoconstrictor response to repeated exercise. The aim of our study was to determine whether inhaled prostaglandin (PG)E2 attenuates exercise-induced bronchoconstriction or methacholine airway responsiveness in asthmatic subjects. Eight subjects with mild stable asthma and exercise bronchoconstriction were studied on 4 separate days, 48 h apart. Subjects inhaled PGE2 or placebo in a randomized, crossover, double- blind fashion, 30 min prior to an exercise challenge or a methacholine challenge. PGE2 inhalation significantly attenuated exercise bronchoconstriction. The mean maximal %fall in FEV1 after exercise was 26% (SEM 3.7%) after placebo, and was 9.7% (SEM 2.7%) after PGE2 (p < 0.001). PGE2 also significantly reduced the duration of exercise bronchoconstriction (p = 0.034). However, PGE2 did not significantly attenuate methacholine airway responsiveness. The geometric mean methacholine provocative concentration causing a 20% fall in FEV1 (PC20) was 0.77 (%SEM 1.48) after placebo day, and 1.41 (%SEM 2.20) after PGE2 (p = 0.30). These results demonstrate that inhaled PGE2 markedly attenuates exercise bronchoconstriction in asthmatic subjects and suggest that this effect is not occurring through functional antagonism of airway smooth muscle.

This article has been cited by other articles:

				S. A. Maher, M. A. Birrell, and M. G. Belvisi Prostaglandin E2 Mediates Cough via the EP3 Receptor: Implications for Future Disease Therapy Am. J. Respir. Crit. Care Med., November 15, 2009; 180(10): 923 - 928. [Abstract] [Full Text] [PDF]

				M. Fernandez-Nieto, B. Sastre, J. Sastre, C. Lahoz, S. Quirce, M. Madero, and V. del Pozo Changes in Sputum Eicosanoids and Inflammatory Markers After Inhalation Challenges With Occupational Agents Chest, November 1, 2009; 136(5): 1308 - 1315. [Abstract] [Full Text] [PDF]

				L. Pujols, P. Benitez, I. Alobid, A. Martinez-Anton, J. Roca-Ferrer, J. Mullol, and C. Picado Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo Eur. Respir. J., March 1, 2009; 33(3): 502 - 508. [Abstract] [Full Text] [PDF]

				P. Rastogi, D. M. Young, and J. McHowat Tryptase activates calcium-independent phospholipase A2 and releases PGE2 in airway epithelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L925 - L932. [Abstract] [Full Text] [PDF]

				T. S. Hallstrand, E. Y. Chi, A. G. Singer, M. H. Gelb, and W. R. Henderson Jr. Secreted Phospholipase A2 Group X Overexpression in Asthma and Bronchial Hyperresponsiveness Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1072 - 1078. [Abstract] [Full Text] [PDF]

				G. L. Larsen, J. Loader, C. Fratelli, J.-k. B. Kang, A. Dakhama, and G. N. Colasurdo Modulation of airway responses by prostaglandins in young and fully grown rabbits Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L239 - L244. [Abstract] [Full Text] [PDF]

				J. W. Card, M. A. Carey, J. A. Bradbury, J. P. Graves, F. B. Lih, M. P. Moorman, D. L. Morgan, L. M. DeGraff, Y. Zhao, J. F. Foley, et al. Cyclooxygenase-1 Overexpression Decreases Basal Airway Responsiveness but Not Allergic Inflammation J. Immunol., October 1, 2006; 177(7): 4785 - 4793. [Abstract] [Full Text] [PDF]

				G. Y. Park and J. W. Christman Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L797 - L805. [Abstract] [Full Text] [PDF]

				J. M. Hartney, K. G. Coggins, S. L. Tilley, L. A. Jania, A. K. Lovgren, L. P. Audoly, and B. H. Koller Prostaglandin E2 protects lower airways against bronchoconstriction Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L105 - L113. [Abstract] [Full Text] [PDF]

				H. Tanaka, S. Kanako, and S. Abe Prostaglandin E2 Receptor Selective Agonists E-Prostanoid 2 and E-Prostanoid 4 May Have Therapeutic Effects on Ovalbumin-Induced Bronchoconstriction Chest, November 1, 2005; 128(5): 3717 - 3723. [Abstract] [Full Text] [PDF]

				K. F. Chung Evaluation of Selective Prostaglandin E2 (PGE2) Receptor Agonists as Therapeutic Agents for the Treatment of Asthma Sci. Signal., September 27, 2005; 2005(303): pe47 - pe47. [Abstract] [Full Text] [PDF]

				T. S. Hallstrand, M. W. Moody, M. M. Wurfel, L. B. Schwartz, W. R. Henderson Jr., and M. L. Aitken Inflammatory Basis of Exercise-induced Bronchoconstriction Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 679 - 686. [Abstract] [Full Text] [PDF]

				H. Harizi, M. Juzan, J.-F. Moreau, and N. Gualde Prostaglandins Inhibit 5-Lipoxygenase-Activating Protein Expression and Leukotriene B4 Production from Dendritic Cells Via an IL-10-Dependent Mechanism J. Immunol., January 1, 2003; 170(1): 139 - 146. [Abstract] [Full Text] [PDF]

				R. Stokes Peebles Jr., K. Hashimoto, J. D. Morrow, R. Dworski, R. D. Collins, Y. Hashimoto, J. W. Christman, K.-H. Kang, K. Jarzecka, J. Furlong, et al. Selective Cyclooxygenase-1 and -2 Inhibitors Each Increase Allergic Inflammation and Airway Hyperresponsiveness in Mice Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1154 - 1160. [Abstract] [Full Text] [PDF]

				R K Woods and F Thien Polyunsaturated fats and asthma Thorax, January 1, 2002; 57(1): 94 - 94. [Full Text] [PDF]

				O. E. Suman and K. C. Beck Role of nitric oxide during hyperventilation-induced bronchoconstriction in the guinea pig J Appl Physiol, April 1, 2001; 90(4): 1474 - 1480. [Abstract] [Full Text] [PDF]

				K. Gomi, F.-G. Zhu, and J. S. Marshall Prostaglandin E2 Selectively Enhances the IgE-Mediated Production of IL-6 and Granulocyte-Macrophage Colony-Stimulating Factor by Mast Cells Through an EP1/EP3-Dependent Mechanism J. Immunol., December 1, 2000; 165(11): 6545 - 6552. [Abstract] [Full Text] [PDF]

				O. E. Suman, J. D. Morrow, K. A. O'Malley, and K. C. Beck Airway function after cyclooxygenase inhibition during hyperpnea-induced bronchoconstriction in guinea pigs J Appl Physiol, November 1, 2000; 89(5): 1971 - 1978. [Abstract] [Full Text] [PDF]

				G. M. GAUVREAU, G. M. RONNEN, R. M. WATSON, and P. M. O'BYRNE Exercise-induced Bronchoconstriction Does Not Cause Eosinophilic Airway Inflammation or Airway Hyperresponsiveness in Subjects with Asthma Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1302 - 1307. [Abstract] [Full Text] [PDF]

				T. V. HARTERT, R. T. DWORSKI, B. G. MELLEN, J. A. OATES, J. J. MURRAY, and J. R. SHELLER Prostaglandin E2 Decreases Allergen-stimulated Release of Prostaglandin D2 in Airways of Subjects with Asthma Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 637 - 640. [Abstract] [Full Text] [PDF]

				P. J. BARNES Endogenous Inhibitory Mechanisms in Asthma Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S176 - 181. [Full Text] [PDF]

				P. M. O'BYRNE Leukotriene Bronchoconstriction Induced by Allergen and Exercise Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S68 - 72. [Full Text] [PDF]

				W. Wasiak and M. Szmidt A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma Thorax, October 1, 1999; 54(10): 900 - 904. [Abstract] [Full Text]

				J. S. Marshall, K. Gomi, M. G. Blennerhassett, and J. Bienenstock Nerve Growth Factor Modifies the Expression of Inflammatory Cytokines by Mast Cells Via a Prostanoid-Dependent Mechanism J. Immunol., April 1, 1999; 162(7): 4271 - 4276. [Abstract] [Full Text] [PDF]

				G. M. GAUVREAU, R. M. WATSON, and P. M. O'BYRNE Protective Effects of Inhaled PGE2 on Allergen-induced Airway Responses and Airway Inflammation Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 31 - 36. [Abstract] [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				I. McGrogan, L. J. Janssen, J. Wattie, P. M. O'Byrne, and E. E. Daniel Release of epithelium-derived PGE2 from canine trachea after antigen inhalation Am J Physiol Lung Cell Mol Physiol, February 1, 1998; 274(2): L220 - L225. [Abstract] [Full Text] [PDF]